Stay updated on Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now includes updated definitions and timeframes for primary/secondary outcomes (PFS, OS, ORR), added PK data details, and an additional Naples, Italy site.
    Difference
    1.0%
    Check dated 2026-03-23T06:31:50.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-09T00:26:56.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page shows a minor version update from Revision: v3.4.1 to Revision: v3.4.2; no study data or visible content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T15:02:22.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T09:43:58.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page now includes a glossary display option and a new QC metadata label 'Last Update Submitted that Met QC Criteria' along with a 'No FEAR Act Data' notice. The revision footer shows 'Revision: v3.4.0', replacing the previous 'v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-25T00:51:14.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page shows an internal revision label updated from v3.3.3 to v3.3.4, which does not affect the study information or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T23:22:30.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.